- TWD4.59bn
- TWD8.82bn
- TWD6.88bn
Annual income statement for Ampacs, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,998 | 5,679 | 5,052 | 3,861 | 6,881 |
Cost of Revenue | |||||
Gross Profit | 1,245 | 671 | 686 | 730 | 1,264 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 4,325 | 5,698 | 4,957 | 3,685 | 6,290 |
Operating Profit | 673 | -18.9 | 94.7 | 176 | 591 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 605 | -76.5 | 114 | 7.4 | 406 |
Provision for Income Taxes | |||||
Net Income After Taxes | 495 | -46.2 | 74 | -8.23 | 309 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 489 | -49.2 | 73.3 | -6.82 | 310 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 489 | -49.2 | 73.3 | -6.82 | 310 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.61 | -0.303 | 0.494 | -0.04 | 2.11 |
Dividends per Share |